Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2004
08/10/2004US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif)
08/10/2004US6774226 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
08/10/2004US6774225 Antigenized antibody vaccine for foot-and-mouth disease
08/10/2004US6774224 ULBP DNA and polypeptides
08/10/2004US6774223 Polynucleotide for use in the detection and treatment of human cancers
08/10/2004US6774220 Compounds having lectinic properties and their biological applications
08/10/2004US6774219 Candida albicans gene, integrin-like protein, antibodies, and methods of use
08/10/2004US6774218 Drugs, vaccines
08/10/2004US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation
08/10/2004US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders
08/10/2004US6774214 Monocyte-derived homolog of FDF03 protein
08/10/2004US6774213 Contain one mutations in the maw (makes atp work) motif; mutants rely on replacement of wildtype amino acid residues to alter the three-dimensional structure of the maw motif and to change the protein's dna-binding properties
08/10/2004US6774210 Anti-freeze protein derived from lichen, especially umbilicaria antarctica
08/10/2004US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging
08/10/2004US6774119 Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
08/10/2004US6774117 MN gene and protein
08/10/2004US6774108 Administering to mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or a fragment thereof for inhibiting transplant rejection
08/10/2004US6774107 Protein for blocking platelet adhesion
08/10/2004US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI
08/10/2004US6774105 Methods of using latent TGF-β binding proteins
08/10/2004US6773920 Delivery of functional protein sequences by translocating polypeptides
08/10/2004US6773915 Detecting antibodies; culture product
08/10/2004US6773914 PiggyBac transformation system
08/10/2004US6773912 Lantibiotic
08/10/2004US6773911 Homologous recombination
08/10/2004US6773908 From open reading frames; vaccines
08/10/2004US6773904 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
08/10/2004US6773900 End selection in directed evolution
08/10/2004US6773899 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide
08/10/2004US6773895 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
08/10/2004US6773893 Human ABC1 promoter and assays based thereon
08/10/2004US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in
08/10/2004US6773886 Binary encoded sequence tags
08/10/2004US6773880 Bactericides; vaccine development; infection diagnosis;
08/10/2004US6773878 For therapy/drug screening
08/10/2004US6773877 Inhibiting the growth of ice crystals by applying a natural antifreeze protein to form hydrogen bond with ice; applying on aircraft wings, footwear, pathways, foods, plants, cables, windows, transplantable organs, tissue, or blood cells
08/10/2004US6773712 Dirofilaria immitis nucleic acid molecule hybridizes in a solution (consisting of sodium chloride, sodium citrate, water, and 0% formamide at 37 degree c., and washing in above solution), to a prefered nucleic acid sequence
08/10/2004US6773709 Chicken embryo lethal (CELO) virus
08/10/2004US6773707 Employing hybrid antigen complex
08/10/2004US6773705 Restoring nf kappa b activity
08/10/2004CA2273498C Cross-linked protein gels and methods of making them
08/10/2004CA2260365C Differentiation-suppressive polypeptide
08/10/2004CA2255661C Antiangiogenic drug to treat cancer, arthritis and retinopathy
08/10/2004CA2202639C Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles
08/10/2004CA2191872C Beta sheet forming peptides and gels made thereof
08/10/2004CA2145388C Method of controlling polypeptide production in bacteria
08/10/2004CA2129101C Synthetic haemophilus influenzae conjugate vaccine
08/10/2004CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72
08/09/2004CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
08/07/2004CA2457220A1 Inhibitors of staphylococcus aureus primary sigma factor and uses thereof
08/07/2004CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders
08/05/2004WO2004065960A1 Novel screening method
08/05/2004WO2004065938A2 Human osteoporosis gene
08/05/2004WO2004065626A2 A method of sepsis prognosis
08/05/2004WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
08/05/2004WO2004065604A1 Juvenile hormone transmethylase genes and method of using the same
08/05/2004WO2004065603A2 Methods for increasing neisseria protein expression
08/05/2004WO2004065598A1 Method of screening agent for improving memory and learning ability
08/05/2004WO2004065580A2 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures
08/05/2004WO2004065577A2 Polynucleotides and polypeptides associated with the nf-kb pathway
08/05/2004WO2004065576A2 Methods and compositions for the treatment of urological disorder using differential expressed polypeptides
08/05/2004WO2004065575A2 Dna compositon and uses thereof
08/05/2004WO2004065561A2 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
08/05/2004WO2004065556A2 Pet family of efflux proteins
08/05/2004WO2004065555A2 Regulator/promoter for tunable gene expression and metabolite sensing
08/05/2004WO2004065554A2 Human saa3 nucleic acid molecule, protein, and methods of use for same
08/05/2004WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/05/2004WO2004065538A2 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation
08/05/2004WO2004065418A1 Anti-pci neutralizing antibody
08/05/2004WO2004065415A2 L-amino acid oxidase with cytotoxic activity from aplysia punctata
08/05/2004WO2004065414A1 Process for the preparation of hypoallergenic mosaic antigens
08/05/2004WO2004065410A2 Mntf peptides and compositions and methods of use
08/05/2004WO2004065406A2 Rantes-derived peptides with anti-hiv activity
08/05/2004WO2004064868A1 Tarp promoter and uses thereof
08/05/2004WO2004064863A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway
08/05/2004WO2004064861A1 Nerve cell death inhibitor
08/05/2004WO2004064856A2 Proteins involved in the regulation of energy homeostasis
08/05/2004WO2004064854A1 Method for enhancing learning and memory by suppressing the activity of ncx2 protein
08/05/2004WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
08/05/2004WO2004064784A2 Composition and method for preventing or treating a virus infection
08/05/2004WO2004064774A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/05/2004WO2004064740A2 Sperm specific lysozyme-like proteins
08/05/2004WO2004064714A2 Animal model for obesity independently of insulin resistance
08/05/2004WO2004064713A2 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
08/05/2004WO2004064709A2 Thrombolytic agent
08/05/2004WO2004064612A2 Regulation of tgf-b signaling by tomoregulin
08/05/2004WO2004064501A2 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
08/05/2004WO2004064500A2 Transcriptional coactivator asc-2
08/05/2004WO2004064479A2 Neuroprotective therapeutics and assays for identifying the same
08/05/2004WO2004055183A3 Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
08/05/2004WO2004052928A3 Midkine-like protein
08/05/2004WO2004050869A8 PROTEIN BINDING TO Akt2
08/05/2004WO2004047859A3 Prekallikrein depleted plasma derived albumin fraction
08/05/2004WO2004041216A3 Ptpn11 (shp-2) mutations and cancer
08/05/2004WO2004040262A3 Compositions and methods for modifying toxic effects of proteinaceous compounds
08/05/2004WO2004039837A3 Crh responsive genes in cns
08/05/2004WO2004037976A3 NONSENSE-MEDIATED mRNA DECAY
08/05/2004WO2004033645A3 Methods of regulating body weight
08/05/2004WO2004033486A3 Production of homotrimeric fusion proteins
08/05/2004WO2004031242A3 Protein complexes involved in neurological diseases